Literature DB >> 22063004

Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin.

Xianfeng Chen1, Germain J P Fernando, Anthony P Raphael, Sally R Yukiko, Emily J Fairmaid, Clare A Primiero, Ian H Frazer, Lorena E Brown, Mark A F Kendall.   

Abstract

A rapid time to peak serum antibody response following vaccination is particularly important for influenza: the time window between the availability of appropriate antigen and the start of the seasonal epidemic is very short. In this paper, influenza vaccine was delivered to both the epidermis and dermis of mouse skin using densely packed microprojection arrays for vaccination. We found that, after vaccination, around 75% and 90% of the delivered influenza vaccine migrated away from the ear skin within just 2 days and 1 week - respectively. And the time to peak serum antibody response was as early as 2 weeks. This result matches the kinetics achieved by intramuscular injection of liquid vaccine to muscle. Thus, we demonstrate that skin delivery of small vaccine volumes discretely by thousands of densely packed microprojections neither induces delay in kinetics nor interferes with the long-lasting antibody response; compared to conventional intramuscular injection. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22063004     DOI: 10.1016/j.jconrel.2011.10.026

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  8 in total

Review 1.  Microneedle Coating Methods: A Review with a Perspective.

Authors:  Rohan S J Ingrole; Harvinder Singh Gill
Journal:  J Pharmacol Exp Ther       Date:  2019-06-07       Impact factor: 4.030

2.  Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.

Authors:  Elena V Vassilieva; Haripriya Kalluri; Devin McAllister; Misha T Taherbhai; E Stein Esser; Winston P Pewin; Joanna A Pulit-Penaloza; Mark R Prausnitz; Richard W Compans; Ioanna Skountzou
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

3.  Extended delivery of vaccines to the skin improves immune responses.

Authors:  Jessica C Joyce; Hila E Sella; Heather Jost; Matthew J Mistilis; E Stein Esser; Pallab Pradhan; Randall Toy; Marcus L Collins; Paul A Rota; Krishnendu Roy; Ioanna Skountzou; Richard W Compans; M Steven Oberste; William C Weldon; James J Norman; Mark R Prausnitz
Journal:  J Control Release       Date:  2019-05-06       Impact factor: 9.776

Review 4.  The potential role of using vaccine patches to induce immunity: platform and pathways to innovation and commercialization.

Authors:  Kamran Badizadegan; James L Goodson; Paul A Rota; Kimberly M Thompson
Journal:  Expert Rev Vaccines       Date:  2020-03-17       Impact factor: 5.217

5.  Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing.

Authors:  Hwee-Ing Ng; Germain J P Fernando; Alexandra C I Depelsenaire; Mark A F Kendall
Journal:  Sci Rep       Date:  2016-07-11       Impact factor: 4.379

Review 6.  Microfabrication for Drug Delivery.

Authors:  Brendan Koch; Ilaria Rubino; Fu-Shi Quan; Bongyoung Yoo; Hyo-Jick Choi
Journal:  Materials (Basel)       Date:  2016-08-01       Impact factor: 3.623

7.  High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responses.

Authors:  David A Muller; Germain J P Fernando; Nick S Owens; Christiana Agyei-Yeboah; Jonathan C J Wei; Alexandra C I Depelsenaire; Angus Forster; Paul Fahey; William C Weldon; M Steven Oberste; Paul R Young; Mark A F Kendall
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379

Review 8.  Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application.

Authors:  Ana Sara Cordeiro; Yogita Patil-Sen; Maitreyi Shivkumar; Ronak Patel; Abdulwahhab Khedr; Mohamed A Elsawy
Journal:  Pharmaceutics       Date:  2021-12-05       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.